Figure 3. Cost effectiveness analysis for the combination HIV prevention interventions.
Discounted incremental costs and QALYS over 10 years are displayed for combined interventions
ART: Antiretroviral Therapy; HIV: Human Immunodeficiency Virus; HPV: Human Papillomavirus; Dual Vaccine: HIV and HPV Vaccinations; VMMC: Voluntary Male Medical Circumcision; Prep: Pre-Exposure Prophylaxis